Your browser doesn't support javascript.
loading
Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy.
Liu, An-Bu; Liu, Jia; Wang, Sheng; Ma, Lei; Zhang, Jun-Fei.
Afiliação
  • Liu AB; Department of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, 750000, Ningxia, China.
  • Liu J; Medical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, 750000, Ningxia, China.
  • Wang S; Department of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, 750000, Ningxia, China.
  • Ma L; School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750000, Ningxia, China.
  • Zhang JF; Department of Emergency Medical, General Hospital of Ningxia Medical University, Yinchuan, 750000, Ningxia, China. 13895306161@163.com.
Cancer Cell Int ; 24(1): 198, 2024 Jun 04.
Article em En | MEDLINE | ID: mdl-38835077
ABSTRACT
Translationally controlled tumor protein (TCTP), also known as histamine-releasing factor (HRF) or fortilin, is a highly conserved protein found in various species. To date, multiple studies have demonstrated the crucial role of TCTP in a wide range of cellular pathophysiological processes, including cell proliferation and survival, cell cycle regulation, cell death, as well as cell migration and movement, all of which are major pathogenic mechanisms of tumorigenesis and development. This review aims to provide an in-depth analysis of the functional role of TCTP in tumor initiation and progression, with a particular focus on cell proliferation, cell death, and cell migration. It will highlight the expression and pathological implications of TCTP in various tumor types, summarizing the current prevailing therapeutic strategies that target TCTP.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Cell Int Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Cell Int Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China